Code | 44183 | ||||||||||
MA number | EU/1/97/033/004 | ||||||||||
Product Form: | sol inj 12x0,5 ml/30 µg (napln. inj. striek.+ ihla) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Biogen Netherlands B.V., Netherland | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Intramuscular use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application |
MA issued: | 13.03.1997 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | DHPC interferóny final 25 8 2014.pdf |
Safety feature | Yes |
Data update: | 17.01.2023 |